MoneyWorks4Me

Lupin informs board to consider Audited Financial Results

29 Apr 2013 Evaluate

Lupin has informed that a meeting of the Board of Directors of the Company will be held on May 08, 2013, to consider stand-alone and consolidated annual audited financial results for the year ended March 31, 2013 and recommend dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..